Clinical Trial Update: Comparing Cefepime Versus Cefazolin Plus Ceftazidime for CAPD-associated Peritonitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial completed comparing cefepime monotherapy to a cefazolin plus ceftazidime regimen for peritoneal dialysis-associated peritonitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Dialysis-associated Peritonitis

Drugs mentioned

• CEFAZOLIN (cefazolin sodium)
• Cefepime (cefepime)
• ceftazidime (ceftazidime)

Snippet

Sponsor: Chulalongkorn University | Conditions: Peritoneal Dialysis Associated Peritonitis | Phase 4 | Status: COMPLETED